4.5 Article

The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Association of Childhood Externalizing, Internalizing, and Comorbid Symptoms With Long-term Economic and Social Outcomes

Francis Vergunst et al.

Summary: This study used 32 years of longitudinal data and found that children with externalizing, internalizing, or comorbid symptoms during school age were at increased risk for poor economic and social outcomes in the long term. Especially, children exhibiting comorbid problems were particularly vulnerable. Early detection and support are crucial for these children.

JAMA NETWORK OPEN (2023)

Article Genetics & Heredity

The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: Evidence from Finland

Edvard Johansson et al.

Summary: This study investigated the impact of neurofibromatosis 1 (NF1) on economic well-being and found that individuals with NF1 had worse economic outcomes compared to those without NF1. The effect of NF1 on economic well-being was partially explained by factors such as low education, increased morbidity, and reduced labor market participation. NF1 had a larger negative effect on income from work than on total income, indicating partial compensation from the Finnish social security system. The study also found that NF1 had a greater impact on economic inequality for men than for women.

GENETICS IN MEDICINE (2022)

Article Genetics & Heredity

A rare disease and education: Neurofibromatosis type 1 decreases educational attainment

Edvard Johansson et al.

Summary: NF1 is associated with reduced educational attainment, with individuals more likely to pursue vocational education. History of cancer and developmental disorders are major predictors of lack of secondary education. NF1 decreases the attainment of Bachelor's and Master's degrees.

CLINICAL GENETICS (2021)

Article Medicine, General & Internal

Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020

Jace P. Landry et al.

Summary: This study investigated the prevalence of neoplasms and outcomes among patients with NF1, finding that these patients develop various tumors at a younger age and more frequently than the general population. Patients with certain neoplasms like undifferentiated pleomorphic sarcoma, high-grade glioma, and malignant peripheral nerve sheath tumor had significantly lower disease-specific survival rates.

JAMA NETWORK OPEN (2021)

Article Genetics & Heredity

Increased risk for dementia in neurofibromatosis type 1

Roope A. Kallionpaa et al.

Summary: The study suggests that individuals with NF1 have a slightly higher risk of developing dementia, particularly Alzheimer's disease, compared to the general population.

GENETICS IN MEDICINE (2021)

Article Genetics & Heredity

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

Eric Legius et al.

Summary: The study revised the diagnostic criteria for neurofibromatosis type 1 (NF1) and established criteria for Legius syndrome (LGSS) by combining major developments in genetics, ophthalmology, dermatology, and neuroimaging. Consensus on minimal clinical and genetic criteria for diagnosing and differentiating NF1 and LGSS was reached, with recommendations for mosaic forms of these conditions. Continued refinement of these new criteria will be necessary to study their diagnostic properties, reconsider criteria not included, and identify new features of the conditions, hence proposing an initiative to periodically update the diagnostic criteria for NF1 and LGSS.

GENETICS IN MEDICINE (2021)

Article Psychiatry

Predictors of cognitive, behavioural and academic difficulties in NF1

Marie-Maude Geoffray et al.

Summary: This study investigated the impact factors of cognitive, behavioral, and academic outcomes in NF1 patients, finding that family history, socioeconomic status, and neurological problems independently influence the cognitive, behavioral, and academic outcomes of NF1 patients.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

Article Genetics & Heredity

The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1

Frank D. Buono et al.

Summary: The study found that barriers to successful employment have a greater impact on the quality of life, anxiety, and depression of individuals with NF1 compared to matched controls. Poorer employment barriers observed among people with a genetic disease can impact mental health and quality of life.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Article Biochemistry & Molecular Biology

Educational delay and attainment in persons with neurofibromatosis 1 in Denmark

Karoline Doser et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2019)

Article Genetics & Heredity

Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1

Alanna M. Kongkriangkai et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)

Article Genetics & Heredity

Prevalence of neurofibromatosis type 1 in the Finnish population

Roope A. Kallionpaa et al.

GENETICS IN MEDICINE (2018)

Article Clinical Neurology

Cutaneous neurofibromas Current clinical and pathologic issues

Nicolas Ortonne et al.

NEUROLOGY (2018)

Article Genetics & Heredity

Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study

Ashley Cannon et al.

ORPHANET JOURNAL OF RARE DISEASES (2018)

Article Medicine, General & Internal

Neurofibromatosis type 1

David H. Gutmann et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Clinical Neurology

Neurodevelopmental disorders in children with neurofibromatosis type 1

Alecia C. Vogel et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2017)

Article Genetics & Heredity

The pregnancy in neurofibromatosis 1: A retrospective register-based total population study

Jussi Leppavirta et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)

Article Genetics & Heredity

Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning

Ellen Plasschaert et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2016)

Article Oncology

Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1

Elina Uusitalo et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Clinical Neurology

Cognition in children with neurofibromatosis type 1: data from a population-based study

Annukka Lehtonen et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2015)

Letter Dermatology

Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland

Elina Uusitalo et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)

Article Psychology, Developmental

Impact of ADHD in Adults With Neurofibromatosis Type 1: Associated Psychological and Social Problems

Victor-Felix Mautner et al.

JOURNAL OF ATTENTION DISORDERS (2015)

Article Obstetrics & Gynecology

Neurofibromatosis type 1 and pregnancy complications: a population-based study

Anna R. Terry et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)

Article Education, Special

Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group

M. -J. Descheemaeker et al.

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2013)

Article Genetics & Heredity

Life expectancy in hereditary cancer predisposing diseases: an observational study

Anna Wilding et al.

JOURNAL OF MEDICAL GENETICS (2012)

Review Pathology

The Pathoetiology of Neurofibromatosis 1

Eeva-Mari Jouhilahti et al.

AMERICAN JOURNAL OF PATHOLOGY (2011)

Article Genetics & Heredity

Speech Characteristics in Neurofibromatosis Type 1

Lotta Alivuotila et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)

Review Genetics & Heredity

Skeletal Abnormalities in Neurofibromatosis Type 1: Approaches to Therapeutic Options

Florent Elefteriou et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)

Article Medicine, General & Internal

Age-associated cognitive decline

Ian J. Deary et al.

BRITISH MEDICAL BULLETIN (2009)

Article Clinical Neurology

Impact of neurofibromatosis type 1 on school performance

Lianne C. Krab et al.

JOURNAL OF CHILD NEUROLOGY (2008)

Review Clinical Neurology

Neuro-fibromatosis 1 and neuro-fibromatosis 2: a twenty first century perspective

Rosalie E. Ferner

LANCET NEUROLOGY (2007)

Article Oncology

A prospective study of neurofibromatosis type 1 cancer incidence in the UK

L. Walker et al.

BRITISH JOURNAL OF CANCER (2006)

Article Genetics & Heredity

Mortality in neurofibromatosis 1: An analysis using US death certificates

SA Rasmussen et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2001)